mTOR inhibitor INK128 promotes wound healing by regulating MDSCs

[1]  M. Martinez-Fierro,et al.  Myeloid-Derived Suppressor Cells Show Different Frequencies in Diabetics and Subjects with Arterial Hypertension , 2019, Journal of diabetes research.

[2]  Huicui Meng,et al.  Increased Adiposity Enhances the Accumulation of MDSCs in the Tumor Microenvironment and Adipose Tissue of Pancreatic Tumor-Bearing Mice and in Immune Organs of Tumor-Free Hosts , 2019, Nutrients.

[3]  J. Steinbach,et al.  Second Generation mTOR Inhibitors as a Double-Edged Sword in Malignant Glioma Treatment , 2019, International journal of molecular sciences.

[4]  M. Xiang,et al.  mTOR: A double‐edged sword for diabetes , 2019, Journal of leukocyte biology.

[5]  Y. Kanda,et al.  Pharmacological inhibition of mTORC1 but not mTORC2 protects against human disc cellular apoptosis, senescence, and extracellular matrix catabolism through Akt and autophagy induction. , 2019, Osteoarthritis and cartilage.

[6]  Satish Patel,et al.  Mechanistic insight into diabetic wounds: Pathogenesis, molecular targets and treatment strategies to pace wound healing. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[7]  L. Ding,et al.  mTOR inhibitor INK128 attenuates systemic lupus erythematosus by regulating inflammation-induced CD11b+Gr1+ cells. , 2019, Biochimica et biophysica acta. Molecular basis of disease.

[8]  A. E. Sousa,et al.  MDSCs in infectious diseases: regulation, roles, and readjustment , 2018, Cancer Immunology, Immunotherapy.

[9]  Jie Tian,et al.  Roles of Myeloid-Derived Suppressor Cell Subpopulations in Autoimmune Arthritis , 2018, Front. Immunol..

[10]  H. Xiong,et al.  Arctigenin Ameliorates Inflammation by Regulating Accumulation and Functional Activity of MDSCs in Endotoxin Shock , 2018, Inflammation.

[11]  Yayi Hou,et al.  mTOR inhibitor INK128 attenuates dextran sodium sulfate‐induced colitis by promotion of MDSCs on Treg cell expansion , 2018, Journal of cellular physiology.

[12]  Q. Tan,et al.  Wnt7a promotes wound healing by regulation of angiogenesis and inflammation: Issues on diabetes and obesity. , 2018, Journal of dermatological science.

[13]  K. Lalić,et al.  mTOR Inhibitor Therapy and Metabolic Consequences: Where Do We Stand? , 2018, Oxidative medicine and cellular longevity.

[14]  Thomas D. Schmittgen,et al.  CD44 positive and sorafenib insensitive hepatocellular carcinomas respond to the ATP-competitive mTOR inhibitor INK128 , 2018, Oncotarget.

[15]  A. Palmer,et al.  The Role of Macrophages in Acute and Chronic Wound Healing and Interventions to Promote Pro-wound Healing Phenotypes , 2018, Front. Physiol..

[16]  H. Raslan,et al.  CD33+ HLA-DR– Myeloid-Derived Suppressor Cells Are Increased in Frequency in the Peripheral Blood of Type1 Diabetes Patients with Predominance of CD14+ Subset , 2018, Open access Macedonian journal of medical sciences.

[17]  R. Z. Murray,et al.  Macrophage Phenotypes Regulate Scar Formation and Chronic Wound Healing , 2017, International journal of molecular sciences.

[18]  Katherine A. Gallagher,et al.  Macrophage-Mediated Inflammation in Normal and Diabetic Wound Healing , 2017, The Journal of Immunology.

[19]  L. Ding,et al.  Exosomal miR‐146a Contributes to the Enhanced Therapeutic Efficacy of Interleukin‐1β‐Primed Mesenchymal Stem Cells Against Sepsis , 2017, Stem cells.

[20]  Mikaël M. Martino,et al.  Promoting tissue regeneration by modulating the immune system. , 2017, Acta biomaterialia.

[21]  Yan Zhang,et al.  Accumulation of myeloid-derived suppressor cells (MDSCs) induced by low levels of IL-6 correlates with poor prognosis in bladder cancer , 2017, Oncotarget.

[22]  D. Sabatini,et al.  mTOR Signaling in Growth, Metabolism, and Disease , 2017, Cell.

[23]  T. Zhu,et al.  The mTOR signal regulates myeloid-derived suppressor cells differentiation and immunosuppressive function in acute kidney injury , 2017, Cell Death & Disease.

[24]  Bin Guo,et al.  Hyaluronan oligosaccharides promote diabetic wound healing by increasing angiogenesis , 2016, Pharmacological reports : PR.

[25]  D. Edwards,et al.  Erratum: Oncogenic mTOR signalling recruits myeloid-derived suppressor cells to promote tumour initiation , 2016, Nature Cell Biology.

[26]  A. Doğan,et al.  Boron promotes streptozotocin-induced diabetic wound healing: roles in cell proliferation and migration, growth factor expression, and inflammation , 2016, Molecular and Cellular Biochemistry.

[27]  T. Wynn,et al.  Macrophages in Tissue Repair, Regeneration, and Fibrosis. , 2016, Immunity.

[28]  Yang Zhao,et al.  mTOR masters monocytic myeloid-derived suppressor cells in mice with allografts or tumors , 2016, Scientific Reports.

[29]  T. Weichhart,et al.  Regulation of innate immune cell function by mTOR , 2015, Nature Reviews Immunology.

[30]  J. Buse,et al.  Myeloid-derived suppressor cells are increased in frequency but not maximally suppressive in peripheral blood of Type 1 Diabetes Mellitus patients. , 2014, Clinical immunology.

[31]  M. Sade-Feldman,et al.  Tumor necrosis factor-α blocks differentiation and enhances suppressive activity of immature myeloid cells during chronic inflammation. , 2013, Immunity.

[32]  James A. Hutchinson,et al.  IFN-γ-induced iNOS expression in mouse regulatory macrophages prolongs allograft survival in fully immunocompetent recipients. , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

[33]  K. Maruyama,et al.  Topical simvastatin accelerates wound healing in diabetes by enhancing angiogenesis and lymphangiogenesis. , 2012, The American journal of pathology.

[34]  Nicholas T. Ingolia,et al.  The translational landscape of mTOR signalling steers cancer initiation and metastasis , 2012, Nature.

[35]  S. Leibovich,et al.  Regulation of Macrophage Polarization and Wound Healing. , 2012, Advances in wound care.

[36]  T. Koh,et al.  Dysregulation of monocyte/macrophage phenotype in wounds of diabetic mice. , 2011, Cytokine.

[37]  J. Bottomley,et al.  Economic costs of diabetes in the US in 2007 — Implications for Europe , 2008 .

[38]  Vincent Falanga,et al.  Wound healing and its impairment in the diabetic foot , 2005, The Lancet.

[39]  A. Bartolomé,et al.  Role of the mammalian target of rapamycin (mTOR) complexes in pancreatic β-cell mass regulation. , 2014, Vitamins and hormones.

[40]  Shuhui He,et al.  Electrospun fibers with plasmid bFGF polyplex loadings promote skin wound healing in diabetic rats. , 2012, Molecular pharmaceutics.

[41]  J. Leahy.  Economic Costs of Diabetes in the U.S. in 2007 , 2008 .

[42]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..